---
DrugClass: "[[Anticoagulant and Thrombolytic Drugs]]"
SubClass: "[[Antiplatelet Agents]]"
DrugClassContra: "[[Antiplatelet Agents#Contraindications]]"
DrugClassAdverse: "[[Antiplatelet Agents#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
BrandName: Brilinta
Chapter: "36"
KindleLinkChap: "[Chapter 36](kindle://book?action=open&asin=B09FRF11YJ&location=19929)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases:
---
```smiles
CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Acute coronary syndrome
90â€“ 180 mg orally daily

### Contraindications
See `= this.DrugClassContra`

### Interactionside/Adverse Effects
See `= this.DrugClassAdverse`
Bleeding

### Interactions

`= this.ChemLink+this.file.name`

 